Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 3, 2026
Reporting Period: Quarter ended June 30, 2026
This filing serves as a notification that the Company issued a press release announcing its financial results for the second quarter of 2026. The filing also discloses upcoming investor and analyst meetings scheduled for August and September 2026.
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
- Investor Relations: The Company plans to participate in various meetings with investors and analysts during August and September 2026.
- Materials: Presentation materials for these meetings are available as Exhibit 99.2 and on the Company's Investor Relations website.
- Legal Disclaimer: Information in Items 2.02 and 7.01, including the press release and presentation materials, is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific revenue and earnings figures in the press release (Exhibit 99.1) as they are not listed in the 8-K body.
- Review the presentation materials (Exhibit 99.2) for updated guidance and strategic outlook.
- Confirm the dates and topics of the upcoming investor meetings in August and September 2026.
- Note that the financial data in this filing is not subject to the liabilities of Section 18 of the Exchange Act.